approved EB-2 (NIW)

Postdoctoral Research Associate

Biochemistry And Molecular Biology · Sri Lanka · 2025-04-29

Processing Time
488 days
Decision Date
2025-04-29
Location
Missouri
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research into how DNA replication stress responses are triggered by chemotherapeutic agents. This work aims to identify new drug targets for precision treatment and improve the efficacy of targeted cancer therapies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses cancer's high mortality and economic burden in the U.S. through targeted therapy advancements.

2 Well-positioned to Advance Endeavor Met

The petitioner is well-positioned due to her record of 13 publications, 219 citations, and NIH-funded research background.

3 Balance of Interests Met

It was determined that her contributions to cancer treatment strategies provide a benefit that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on 13 peer-reviewed publications, 4 of which were first-authored, and a total of 219 citations. Her expertise was further evidenced by completing at least 2 peer reviews and receiving funding support from the National Institutes of Health (NIH).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 162 days 2022-07-19
The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.

Research Fellow

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 330 days 2025-04-14
The petitioner proposes to identify molecular mechanisms underlying chemotherapeutic resistance and develop molecular diagnostics for solid tumors. This work involves investigating patient-derived organoid cultures, CRISPR engineering, and high-throughput drug testing to improve early cancer detection and patient outcomes.

Postdoctoral Researcher

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 26 days 2025-06-02
The petitioner proposes to continue research in cancer biology, specifically exploring the molecular mechanisms behind tumor progression and drug resistance. This work focuses on identifying novel therapeutic targets to inform the development of advanced combination therapies and precision medicine paradigms. The intended impact is to improve patient survival rates by creating safer and more effective treatment options for cancers that have evolved resistance to conventional therapies.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-29.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 488 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist